Under Greg Abel Apple Stock Likely to Remain a Core Holding in Berkshire Hathaways Portfolio Canadian Biotech Sector Update Key Opportunities in 2026 Markets Increase Odds of Fed Rate Hike After Hot Inflation Data Pricing Out Cuts Through 2027 Inflation Broadens Beyond Oil and Iran as Consumer Prices Show Signs of Reacceleration Lindsey Column Highlights AIs RealityBending Impact Truth Stranger Than Fiction CAE Q4 Earnings Call Highlights Insights from the Latest Quarterly Update US Stock Markets Closed for Memorial Day SP 500 Nasdaq to Observe Holiday Traders Speculate Next US Government Stake IonQ Micron Anduril Lead Predictions Trump Reverses AI Executive Order Dropping Safety Review Requirement for New Models Singtel Shares Decline on Rights Issue News Analysts Back Digital Infrastructure Shift Dave Busters PLAY Q1 2026 Earnings Massive EPS Miss Sends Stock Higher ST Bancorp STBA Q1 2026 Earnings EPS Beats Consensus by 672 Shares Edge Higher YTRA Q1 2026 Earnings EPS Misses Estimates Amid Stock Rally OPAD Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares MSDL Q1 2026 Earnings Narrow Earnings Beat as Stock Slips Western Midstream Partners Q1 2026 Earnings EPS Beats Estimates by 1391 Stock Rises RenX Enterprises RENX Surges 113 Key Levels and Potential Drivers Banco De Chile ADS BCH Gains as Session Volume Surges Above Support Carnival Plc CUK Surges 656 as Cruise Demand Drives Momentum Toward Key Resistance Fusemachines Inc FUSE Nudges Higher as Support Holds at 135 Howmet Aerospace HWM Gains 164 as Aerospace Demand Lifts Shares Toward Resistance Popular Inc BPOP Edges Higher Key Levels in Focus Context Therapeutics Inc CNTX Shows Modest Gains Near Key Resistance Level Niagen Bioscience Inc NAGE Retreats 343 as Shares Approach Key Support First Internet Bancorp INBK Holds Steady Near Support Amid Cautious Trading EquipmentSharecom Inc EQPT Gains Momentum Shares Climb 56 on Strong Volume Real Messenger Corporation RMSG Holds Steady Near Support After Minor Decline Trump Maintains Iran Naval Blockade Signals No Rush for Deal MODD Q3 2025 Earnings EPS Misses Expectations Stock Gains 89 Gain Therapeutics GANX Edges Higher as Shares Approach Key Resistance Level